Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Holmes FA, Moy B, Delaloge S, Chia SKL, Ejlertsen B, Mansi J, Iwata H, Gnant M, Buyse M, Barrios CH, Silovski T, Šeparović R, Bashford A, Zotano AG, Denduluri N, Patt D, Gokmen E, Gore I, Smith JW 2nd, Loibl S, Masuda N, Tomašević Z, Petráková K, DiPrimeo D, Wong A, Martin M, Chan A; ExteNET Study Group. Holmes FA, et al. Among authors: silovski t. Eur J Cancer. 2023 May;184:48-59. doi: 10.1016/j.ejca.2023.02.002. Epub 2023 Feb 10. Eur J Cancer. 2023. PMID: 36898233 Free article. Clinical Trial.
Impact of the coronavirus disease pandemic on cancer care in Croatia: a multicentre cross-sectional study.
Kelemenic-Drazin R, Budisavljevic A, Plavetic ND, Fucak IK, Silovski T, Dobric VT, Nalbani M, Curic Z, Boric-Mikez Z, Ladenhauser T, Trivanovic D, Vojnovic Z, Tomas I, Plestina S. Kelemenic-Drazin R, et al. Among authors: silovski t. Ecancermedicalscience. 2021 Jul 7;15:1263. doi: 10.3332/ecancer.2021.1263. eCollection 2021. Ecancermedicalscience. 2021. PMID: 34567248 Free PMC article.
Analysis of colon cancer features in Croatia.
Silovski H, Buković D, Silovski T, Jelincić Z, Majerović M, Malojcić B. Silovski H, et al. Among authors: silovski t. Coll Antropol. 2008 Mar;32(1):177-86. Coll Antropol. 2008. PMID: 18496911
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.
Turković L, Bočkor L, Ekpenyong O, Silovski T, Lovrić M, Crnković S, Nigović B, Sertić M. Turković L, et al. Among authors: silovski t. Pharmaceuticals (Basel). 2022 May 16;15(5):614. doi: 10.3390/ph15050614. Pharmaceuticals (Basel). 2022. PMID: 35631440 Free PMC article.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SKL, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J 2nd, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M; ExteNET Study Group. Chan A, et al. Among authors: silovski t. Lancet Oncol. 2016 Mar;17(3):367-377. doi: 10.1016/S1470-2045(15)00551-3. Epub 2016 Feb 10. Lancet Oncol. 2016. PMID: 26874901 Clinical Trial.
Rapid hair depigmentation in patient treated with pazopanib.
Šeparović R, Pavlović M, Silovski T, Tečić Vuger A. Šeparović R, et al. Among authors: silovski t. BMJ Case Rep. 2018 Aug 23;2018:bcr2018224209. doi: 10.1136/bcr-2018-224209. BMJ Case Rep. 2018. PMID: 30139781 Free PMC article.
28 results